Drug intelligence / Profile preview

PreBioGyn

Development stage: Preclinical
Lead developer: Glyciome
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Vaginal

Overview

PreBioGyn is a prebiotic vaginal gel and delivery system developed to optimize vaginal health and reduce the risk of cervical cancer. The product is designed to restore and maintain healthy vaginal microbiota, stabilize pH levels, and support mucosal function, thereby preventing dysbiosis-induced inflammation and mucosal microtrauma—biological factors known to increase the risk of cervical cancer development. Developed through an NIH/NCI-sponsored Small Business Technology Transfer (STTR) program, PreBioGyn has undergone clinical evaluation for user acceptability, sensory characteristics (such as lubricity and tackiness), and applicator usability compared to existing vaginal pH-buffering products. The system consists of a prebiotic gel formulation and a specialized intravaginal applicator designed for ease of use and effective dosing.

Brand names: PreBioGyn

Beyond the preview

Go deeper on PreBioGyn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PreBioGyn.

Explore the full profile